Nonstaining with MMP-9 was highest in the atrophic endometrium (80%), which significantly differed from the serous and all grades of endometrioid endometrial carcinomas (0%) (p < 0.05). This evidence concerns the gene MMP9 and endometrial endometrioid carcinoma.